Healthcare Medical Devices Biotechnology

Cannabis Drugs Market

Global Industry Analysis and Forecast 2023-2030

Pages : 120

Base Year : 2022

Release Year : May 2024

Format : Pdf Ppt Xls

Report ID: KR 320

Author : Omkar R.

Base Year

2022

Forecast Year

2023-2030

Historical Years

2018-2021

Market Value (2022)

USD 12.34 BIllion

Forecasted Value (2030)

USD 22.23 Billion

CAGR (2023 – 2030)

7.63%

Fastest Growing Region (2023 - 2030)

Asia Pacific

Largest Region

North America

By Product Type

Flower, Oil, Tinctures

By Application

Chronic Pain, Migraine, Cancer, Arthritis, Diabetes, AIDS, Parkinson's Disease, Epilepsy, Muscle spasms, Depression and Anxiety

By End User

Pharmaceutical Industries, Hospitals, Research and Development Centers, Homecare Settings and Rehab Centers


TABLE OF CONTENT

1 INTRODUCTION OF THE GLOBAL CANNABIS DRUGS MARKET 
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Limitations
1.5 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 Data Collection
3.1.1 Secondary Sources
3.1.2 Primary Sources
3.1.3 Research Flow
3.2 Subject Matter Expert Advice
3.3 Quality Check
3.4 Final Review
3.5 Bottom-Up Approach
3.6 Top-down Approach

4 GLOBAL CANNABIS DRUGS MARKET OUTLOOK
4.1 Market Evolution
4.2 Overview
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.3.4 Challenges
4.4 Pricing Analysis
4.5 Porter’s Five Forces Analysis
4.6 Value Chain Analysis
4.7 Macroeconomic Analysis

5 IMPACT OF RUSSIA-UKRAINE WAR

6 GLOBAL CANNABIS DRUGS MARKET, BY PRODUCT TYPE
6.1 Overview
6.2 Flower
6.3 Oil
6.4 Tinctures

7 GLOBAL CANNABIS DRUGS MARKET, BY APPLICATION
7.1 Overview
7.2 Chronic Pain
7.3 Migraine
7.4 Cancer
7.5 Arthritis
7.6 Diabetes
7.7 AIDS
7.8 Parkinson's Disease
7.9 Epilepsy
7.10 Muscle spasms
7.11 Depression and Anxiety

8 GLOBAL CANNABIS DRUGS MARKET, BY END USER
8.1 Overview
8.2 Pharmaceutical Industries
8.3 Hospitals
8.4 Research and Development Centers
8.5 Homecare Settings and Rehab Centers

9 GLOBAL CANNABIS DRUGS MARKET, BY GEOGRAPHY
9.1 Overview

10 NORTH AMERICA 
10.1 U.S.
10.2 Canada
10.3 Mexico

11 EUROPE 
11.1 Germany
11.2 U.K.
11.3 France
11.4 Italy
11.5 Spain
11.6 Russia
11.7 Rest of Europe

12 ASIA-PACIFIC 
12.1 China
12.2 Japan
12.3 India
12.4 South Korea
12.5 Rest of Asia-Pacific

13 MIDDLE EAST & AFRICA 
13.1 GCC
13.2 South Africa
13.3 North Africa
13.4 Rest of Middle East & Africa

14 LATIN AMERICA 
14.1 Brazil
14.2 Argentina
14.3 Rest of South America

15 GLOBAL CANNABIS DRUGS MARKET COMPETITIVE LANDSCAPE
15.1 Overview
15.2 Key Developments
15.3 Key Strategic Developments
15.4 Company Market Ranking
15.5 Regional Footprint
15.6 Industry Footprint

16 COMPANY PROFILES
16.1 Canopy Growth Corporation
16.1.1 Key Facts
16.1.2 Financial Overview
16.1.3 Product Benchmarking
16.1.4 Recent Developments
16.1.5 Winning Imperatives
16.1.6 Current Focus & Strategies
16.1.7 Threat from competition
16.1.8 SWOT Analysis
16.2 Aurora Cannabis Inc.
16.2.1 Key Facts
16.2.2 Financial Overview
16.2.3 Product Benchmarking
16.2.4 Recent Developments
16.2.5 Winning Imperatives
16.2.6 Current Focus & Strategies
16.2.7 Threat from competition
16.2.8 SWOT Analysis
16.3 Tilray Inc.
16.3.1 Key Facts
16.3.2 Financial Overview
16.3.3 Product Benchmarking
16.3.4 Recent Developments
16.3.5 Winning Imperatives
16.3.6 Current Focus & Strategies
16.3.7 Threat from competition
16.3.8 SWOT Analysis
16.4 Cronos Group Inc.
16.4.1 Key Facts
16.4.2 Financial Overview
16.4.3 Product Benchmarking
16.4.4 Recent Developments
16.4.5 Winning Imperatives
16.4.6 Current Focus & Strategies
16.4.7 Threat from competition
16.4.8 SWOT Analysis
16.5 GW Pharmaceuticals plc
16.5.1 Key Facts
16.5.2 Financial Overview
16.5.3 Product Benchmarking
16.5.4 Recent Developments
16.5.5 Winning Imperatives
16.5.6 Current Focus & Strategies
16.5.7 Threat from competition
16.5.8 SWOT Analysis
16.6 Aphria Inc.
16.6.1 Key Facts
16.6.2 Financial Overview
16.6.3 Product Benchmarking
16.6.4 Recent Developments
16.7 HEXO Corp
16.7.1 Key Facts
16.7.2 Financial Overview
16.7.3 Product Benchmarking
16.7.4 Recent Developments
16.8 Curaleaf Holdings, Inc.
16.8.1 Key Facts
16.8.2 Financial Overview
16.8.3 Product Benchmarking
16.8.4 Recent Developments
16.9 Green Thumb Industries Inc.
16.9.1 Key Facts
16.9.2 Financial Overview
16.9.3 Product Benchmarking
16.9.4 Recent Developments
16.10 MedMen Enterprises Inc.
16.10.1 Key Facts
16.10.2 Financial Overview
16.10.3 Product Benchmarking
16.10.4 Recent Developments

LIST OF TABLES 

TABLE 1 Global Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 2 Global Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 3 Global Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 4 Global Cannabis Drugs Market Revenue, By Geography, 2020 – 2030 (USD Billion)
TABLE 5 North America Cannabis Drugs Market Revenue, By Country, 2020 – 2030 (USD Billion)
TABLE 6 North America Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 7 North America Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 8 North America Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 9 US Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 10 US Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 11 US Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 12 Canada Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 13 Canada Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 14 Canada Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 15 Mexico Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 16 Mexico Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 17 Mexico Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 18 Europe Cannabis Drugs Market Revenue, By Country, 2020 – 2030 (USD Billion)
TABLE 19 Europe Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 20 Europe Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 21 Europe Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 22 Germany Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 23 Germany Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 24 Germany Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 25 France Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 26 France Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 27 France Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 28 U.K. Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 29 U.K. Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 30 U.K. Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 31 Spain Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 32 Spain Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 33 Spain Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 34 Italy Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 35 Italy Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 36 Italy Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 37 Russia Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 38 Russia Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 39 Russia Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 40 Rest of Europe Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 41 Rest of Europe Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 42 Rest of Europe Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 43 Asia-Pacific Cannabis Drugs Market Revenue, By Country, 2020 – 2030 (USD Billion)
TABLE 44 Asia-Pacific Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 45 Asia-Pacific Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 46 Asia-Pacific Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 47 China Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 48 China Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 49 China Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 50 Japan Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 51 Japan Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 52 Japan Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 53 India Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 54 India Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 55 India Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 56 South Korea Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 57 South Korea Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 58 South Korea Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 59 Rest of Asia-Pacific Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 60 Rest of Asia-Pacific Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 61 Rest of Asia-Pacific Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 62 Middle East and Africa Cannabis Drugs Market Revenue, By Country, 2020 – 2030 (USD Billion)
TABLE 63 Middle East and Africa Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 64 Middle East and Africa Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 65 Middle East and Africa Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 66 GCC Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 67 GCC Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 68 GCC Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 69 North Africa Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 70 North Africa Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 71 North Africa Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 72 South Africa Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 73 South Africa Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 74 South Africa Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 75 Rest of Middle East & Africa Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 76 Rest of Middle East & Africa Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 77 Rest of Middle East & Africa Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 78 Latin America Cannabis Drugs Market Revenue, By Country, 2020 – 2030 (USD Billion)
TABLE 79 Latin America Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 80 Latin America Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 81 Latin America Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 82 Brazil Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 83 Brazil Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 84 Brazil Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 85 Argentina Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 86 Argentina Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 87 Argentina Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 88 Rest of Latin America Cannabis Drugs Market Revenue, By Product Type, 2020 – 2030 (USD Billion)
TABLE 89 Rest of Latin America Cannabis Drugs Market Revenue, By Application, 2020 – 2030 (USD Billion)
TABLE 90 Rest of Latin America Cannabis Drugs Market Revenue, By End User, 2020 – 2030 (USD Billion)
TABLE 91 Company Market Ranking
TABLE 92 Regional Footprint
TABLE 93 Product Benchmarking
TABLE 94 Recent Developments
TABLE 95 Winning Imperatives

LIST OF FIGURES 

FIG. 1 Market Segmentation
FIG. 2 Research Timeline
FIG. 3 Global Cannabis Drugs Market 2020-2030 (USD Billion)
FIG. 4 Global Cannabis Drugs Market Geographical Analysis (CAGR %)
FIG. 5 Global Cannabis Drugs Absolute Market Opportunity (USD Billion)
FIG. 6 Global Cannabis Drugs Market Attractiveness (USD Billion)
FIG. 7 Global Cannabis Drugs Market, By Product Type, 2020-2030 (USD Billion)
FIG. 8 Global Cannabis Drugs Market, By Application, 2020-2030 (USD Billion)
FIG. 9 Global Cannabis Drugs Market, By End User, 2020-2030 (USD Billion)
FIG. 10 Research Methodology
FIG. 11 Research Process
FIG. 12 Bottom-Up Approach
FIG. 13 Top-Bottom Approach
FIG. 14 Market Dynamics Overview
FIG. 15 Porter's Five Forces Analysis
FIG. 16 Value Chain Analysis
FIG. 17 Macroeconomic Analysis
FIG. 18 Global Cannabis Drugs Market Revenue Share, By Product Type, 2020 and 2030 (%)
FIG. 19 Global Cannabis Drugs Market Revenue Share, By Application, 2020 and 2030 (%)
FIG. 20 Global Cannabis Drugs Market Revenue Share, By End User, 2020 and 2030 (%)
FIG. 21 Global Cannabis Drugs Market Revenue Share, By Geographic Regions, 2020 and 2030 (%)
FIG. 22 Market Size and Projections, 2020 - 2030 (USD Billion)
FIG. 23 North America Cannabis Drugs Market Overview Share, By Countries, 2020 – 2030 (%)
FIG. 24 Market Size and Projections, 2020 - 2030 (USD Billion)
FIG. 25 Europe Cannabis Drugs Market Overview Share, By Countries, 2020 – 2030 (%)
FIG. 26 Market Size and Projections, 2020 - 2030 (USD Billion)
FIG. 27 Asia-Pacific Cannabis Drugs Market Overview Share, By Countries, 2020 – 2030 (%)
FIG. 28 Market Size and Projections, 2020 - 2030 (USD Billion)
FIG. 29 Middle East & Africa Cannabis Drugs Market Overview Share, By Countries, 2020 – 2030 (%)
FIG. 30 Market Size and Projections, 2020 - 2030 (USD Billion)
FIG. 31 Latin America Cannabis Drugs Market Overview Share, By Countries, 2020 – 2030 (%)
FIG. 32 Key Strategic Development
FIG. 33 Key Facts
FIG. 34 Financial Overview
FIG. 35 SWOT Analysis

CHOOSE LICENCE TYPE
CUSTOMIZATION OFFERED
  • Check Icon Additional Company Profiles
  • Check Icon Additional Countries
  • Check Icon Cross Segment Analysis
  • Check Icon Regional Market Dynamics
  • Check Icon Country-Level Trend Analysis
  • Check Icon Competitive Landscape Customization
  • Check Icon Extended Forecast Years
  • Check Icon Historical Data Up to 5 Years
Frequently Asked Questions (FAQ's)
The global market is projected to reach USD 22.23 billion by 2030, growing at a CAGR of 7.63% from 2023 to 2030.
The global market was valued at USD 12.34 billion in 2022.
Increasing legalization efforts and expanding acceptance of cannabis for both medical use are driving growth in the cannabis drugs market.
Top manufacturers of cannabis drugs market are Canopy Growth Corporation, Aurora Cannabis Inc., Tilray Inc., Cronos Group Inc., GW Pharmaceuticals plc, Aphria Inc., HEXO Corp, Curaleaf Holdings, Inc., Green Thumb Industries Inc., MedMen Enterprises Inc., and others.
North America is the fastest growing region with the highest CAGR in the forecasted period (2023-2030).
By product type, oil segment will hold the maximum share in the cannabis drugs market in 2030.
Get the latest!

Get actionable strategies to empower your business and market domination

  • Deliver Revenue Impact
  • Demand Supply Patterns
  • Market Estimation
  • Real-Time Insights
  • Market Intelligence
  • Lucrative Growth Opportunities
  • Micro & Macro Economic Factors
  • Futuristic Market Solutions
  • Revenue-Driven Results
  • Innovative Thought Leadership